These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 11014542)
1. Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study. Badie B; Schartner JM; Paul J; Bartley BA; Vorpahl J; Preston JK J Neurosurg; 2000 Oct; 93(4):634-9. PubMed ID: 11014542 [TBL] [Abstract][Full Text] [Related]
2. Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. Badie B; Schartner JM Neurosurgery; 2000 Apr; 46(4):957-61; discussion 961-2. PubMed ID: 10764271 [TBL] [Abstract][Full Text] [Related]
3. Impaired capacity for upregulation of MHC class II in tumor-associated microglia. Schartner JM; Hagar AR; Van Handel M; Zhang L; Nadkarni N; Badie B Glia; 2005 Sep; 51(4):279-85. PubMed ID: 15818597 [TBL] [Abstract][Full Text] [Related]
4. Flow cytometry and in vitro analysis of human glioma-associated macrophages. Laboratory investigation. Parney IF; Waldron JS; Parsa AT J Neurosurg; 2009 Mar; 110(3):572-82. PubMed ID: 19199469 [TBL] [Abstract][Full Text] [Related]
5. The role of human glioma-infiltrating microglia/macrophages in mediating antitumor immune responses. Hussain SF; Yang D; Suki D; Aldape K; Grimm E; Heimberger AB Neuro Oncol; 2006 Jul; 8(3):261-79. PubMed ID: 16775224 [TBL] [Abstract][Full Text] [Related]
6. Human alloreactive CTL interactions with gliomas and with those having upregulated HLA expression from exogenous IFN-gamma or IFN-gamma gene modification. Read SB; Kulprathipanja NV; Gomez GG; Paul DB; Winston KR; Robbins JM; Kruse CA J Interferon Cytokine Res; 2003 Jul; 23(7):379-93. PubMed ID: 14511464 [TBL] [Abstract][Full Text] [Related]
7. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. Ford AL; Goodsall AL; Hickey WF; Sedgwick JD J Immunol; 1995 May; 154(9):4309-21. PubMed ID: 7722289 [TBL] [Abstract][Full Text] [Related]
8. Expression of Fas ligand by microglia: possible role in glioma immune evasion. Badie B; Schartner J; Prabakaran S; Paul J; Vorpahl J J Neuroimmunol; 2001 Nov; 120(1-2):19-24. PubMed ID: 11694315 [TBL] [Abstract][Full Text] [Related]
9. Myeloid cells expressing high level of CD45 are associated with a distinct activated phenotype in glioma. Brandenburg S; Turkowski K; Mueller A; Radev YT; Seidlitz S; Vajkoczy P Immunol Res; 2017 Jun; 65(3):757-768. PubMed ID: 28367602 [TBL] [Abstract][Full Text] [Related]
10. Characterization of microglia/macrophages in gliomas developed in S-100β-v-erbB transgenic rats. Sasaki A; Yokoo H; Tanaka Y; Homma T; Nakazato Y; Ohgaki H Neuropathology; 2013 Oct; 33(5):505-14. PubMed ID: 23331472 [TBL] [Abstract][Full Text] [Related]
11. Effects of steroids and nonsteroid anti-inflammatory agents on vascular permeability in a rat glioma model. Reichman HR; Farrell CL; Del Maestro RF J Neurosurg; 1986 Aug; 65(2):233-7. PubMed ID: 3723182 [TBL] [Abstract][Full Text] [Related]
12. The controversial role of microglia in malignant gliomas. Wei J; Gabrusiewicz K; Heimberger A Clin Dev Immunol; 2013; 2013():285246. PubMed ID: 23983766 [TBL] [Abstract][Full Text] [Related]